THE DEAL, AT A GLANCE
From the announcementInivata
01Who is involvedBacked by NeoGenomicsFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedInivata raised AcquisitionFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersInivata gives NeoGenomics a liquid biopsy platform positioned around blood-based monitoring for cancer recurrence and early cancer detection.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Inivata · Financing Record
Explore source-linked visual explanations for Inivata. Unsupported claims are withheld while source review continues.
Record 682 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →